Phenylbutazone is a member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position. Among its listed roles, it functions as a non-narcotic analgesic, a non-steroidal anti-inflammatory drug, an antirheumatic drug, a peripheral nervous system drug, a metabolite and an EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor. It is grouped under the following drug class(es): Cyclooxygenase‑1 (COX‑1) Inhibitors, Cyclooxygenase‑2 (COX‑2) Inhibitors and Non-Steroidal Anti-Inflammatory Drugs (NSAID). Its therapeutic use is listed as anti-inflammatories and antipyretics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Butapirazol and Butazolidin. Its PubChem CID is 4781.
Phenylbutazone
| CAS No | 50-33-9 |
|---|---|
| Molecular Formula | C19H20N2O2 |
| Molecular Weight | 308.4 g/mol |
| Synonyms | 4-butyl-1,2-diphenylpyrazolidine-3,5-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Phenylbutazone is a member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position. 184 [carbonyl reductase (NADPH)] inhibitor.
The listed CAS number is 50-33-9.
The listed molecular formula is C19H20N2O2.
The listed molecular weight is 308.4 g/mol.
4-butyl-1,2-diphenylpyrazolidine-3,5-dione.
The source lists Butapirazol and Butazolidin.